Féach an leathanach atá againn faoi COVID-19 le haghaidh tairiscintí a bhaineann le riachtanais trealaimh leighis.
The Conference on the Future of Europe is your chance to share your ideas and shape the future of Europe. Make your voice heard!
Netherlands-Amsterdam: Real World Data Subscription
Section I: Contracting authority
Section II: Object
Real World Data Subscription
The European Medicines Agency (EMA) is seeking to sign a contract for access to and use of a set of individual patient-level databases drawn from the population receiving primary care, specialist care and/or hospital care in EU/EEA countries. The Agency must have direct electronic access to data in-house or remotely (from EMA premises), immediately, and on its own initiative.
The set of individual patient-level databases may include electronic health care or claims databases and longitudinal drug prescription, dispensing or other drug utilisation databases.
European Medicines Agency, Domenico Scarlattilaan 6, 1083 HS Amsterdam, THE NETHERLANDS
The Agency wishes to conclude one contract covering:
1) ‘baseline services’ (fixed component), and
2) ‘additional services’ (i.e. access to further databases) as and when required.
The contract will be concluded for an initial period of 4 years with the possibility of two renewals each of 1 year (maximum contract duration is 6 years).
See internet address provided in section I.3)
Section III: Legal, economic, financial and technical information
Section IV: Procedure
Section VI: Complementary information